Metagil GP 1mg/500mg/15mg Tablet SR
Marketer
Precise Lifescience
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metagil GP 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication managing blood glucose. This therapy, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal distress. Missed doses should be taken promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed before treatment commencement. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Metagil GP 1mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Metagil GP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metagil GP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metagil GP 1mg/500mg/15mg sustained-release tablet should be taken with a meal.
Common Side effects of Metagil GP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metagil GP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metagil GP 1mg/500mg/15mg sustained-release tablet should be administered with a meal.
How Metagil GP 1mg/500mg/15mg Tablet SR works:
Metagil GP SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach improves blood sugar management when single or dual therapies prove inadequate. Glimepiride (a sulfonylurea) stimulates pancreatic insulin release to reduce blood glucose. Metformin (a biguanide) acts through reduced hepatic glucose production, slowed intestinal glucose absorption, and enhanced insulin responsiveness. Pioglitazone (a thiazolidinedione) augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metagil GP 1mg/500mg/15mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metagil GP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metagil GP tablets (1mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Metagil GP 1mg/500mg/15mg SR tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metagil GP 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Kidney function should be regularly monitored during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Metagil GP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring a modified dosage. Medical advice is necessary. Metagil GP 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Metagil GP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Metagil GP 1mg/500mg/15mg Tablet SR, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Metagil GP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently